Back to results
US 2023/0053463 A1Published application
Abaloparatide formulations and methods of testing, storing, modifying, and using same
AssigneeRadius Health, Inc.
InventorsGreg Williams, Naveen Palwai, David Hanley
Life of this patent
Estimating the term…
Abstract
Provided herein are newly discovered methods of analyzing abaloparatide samples for abaloparatide isomers. Additionally, methods of storing and treating with abaloparatide in view of the newly discovered abaloparatide isomers are described.
Claims29
A method comprising:
- providing a formulated abaloparatide drug product;
- and
- analyzing the formulated abaloparatide drug product for the presence of beta-Asp10.
A method comprising:
- providing a formulated abaloparatide drug product;
- and
- analyzing the formulated abaloparatide drug product for the presence of beta-Asp10 using an HPLC and/or UPLC using a binary solvent system with a mobile phase comprising an aqueous buffer, wherein said aqueous buffer has a pH range of between 7.5-8.5 prior to mixing with any additional mobile phase solvent.
An abaloparatide drug product manufacturing process comprising:
- providing a formulated abaloparatide drug product;
- and
- analyzing the formulated abaloparatide drug product for the presence of beta-Asp10.
Dependencies are inferred from the claim text.